Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trial
- PMID: 28408545
- PMCID: PMC5719661
- DOI: 10.1136/bmjopen-2016-015301
Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trial
Abstract
Introduction: A model of general practitioner (GP) and pharmacist collaboration in primary care may be an effective strategy to reduce medication-related problems and provide better support to patients after discharge. The aim of this study is to investigate whether a model of structured pharmacist and GP care reduces hospital readmissions in high-risk patients.
Methods and analysis: This protocol details a stepped-wedge, cluster-randomised trial that will recruit participants over 9 months with a 12-month follow-up. There will be 14 clusters each representing a different general practice medical centre. A total of 2240 participants will be recruited from hospital who attend an enrolled medical centre, take five or more long-term medicines or whose reason for admission was related to heart failure or chronic obstructive pulmonary disease.The intervention is a multifaceted service, involving a pharmacist integrated into a medical centre to assist patients after hospitalisation. Participants will meet with the practice pharmacist and their GP after discharge to review and reconcile their medicines and discuss changes made in hospital. The pharmacist will follow-up with the participant and liaise with other health professionals involved in the participant's care. The control will be usual care, which usually involves a patient self-organising a visit to their GP after hospital discharge.The primary outcome is the rate of unplanned, all-cause hospital readmissions over 12 months, which will be analysed using a mixed effects Poisson regression model with a random effect for cluster and a fixed effect to account for any temporal trend. A cost analysis will be undertaken to compare the healthcare costs associated with the intervention to those of usual care.
Ethics and dissemination: The study has received ethical approval (HREC/16/QRBW/410). The study findings will be disseminated through peer-reviewed publications, conferences and reports to key stakeholders.
Trial registration number: ACTRN12616001627448.
Keywords: Readmission; collaboration; medication; pharmacist; primary care; stepped-wedge cluster design.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Figures


Similar articles
-
Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trial.Med J Aust. 2021 Mar;214(5):212-217. doi: 10.5694/mja2.50942. Epub 2021 Feb 12. Med J Aust. 2021. PMID: 33580553 Clinical Trial.
-
OPTimising MEDicine information handover after Discharge (OPTMED-D): protocol for development of a multifaceted intervention and stepped wedge cluster randomised controlled trial.Trials. 2024 Sep 27;25(1):632. doi: 10.1186/s13063-024-08496-w. Trials. 2024. PMID: 39334438 Free PMC article.
-
Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.BMJ Open. 2016 Nov 18;6(11):e012141. doi: 10.1136/bmjopen-2016-012141. BMJ Open. 2016. PMID: 27864247 Free PMC article. Clinical Trial.
-
Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.BMJ Open Qual. 2022 Mar;11(1):e001560. doi: 10.1136/bmjoq-2021-001560. BMJ Open Qual. 2022. PMID: 35241436 Free PMC article. Review.
-
Review of the Role of the Pharmacist in Reducing Hospital Readmissions.J Pharm Pract. 2019 Dec;32(6):617-624. doi: 10.1177/0897190018765500. Epub 2018 Apr 4. J Pharm Pract. 2019. PMID: 29618283 Review.
Cited by
-
Self-management interventions for people with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4. Cochrane Database Syst Rev. 2022. PMID: 35001366 Free PMC article.
-
A realist synthesis of pharmacist-conducted medication reviews in primary care after leaving hospital: what works for whom and why?BMJ Qual Saf. 2020 Oct 30;30(5):418-30. doi: 10.1136/bmjqs-2020-011418. Online ahead of print. BMJ Qual Saf. 2020. PMID: 33127835 Free PMC article. Review.
-
Reducing medication errors at transitions of care is everyone's business.Aust Prescr. 2018 Jun;41(3):73-77. doi: 10.18773/austprescr.2018.021. Epub 2018 Jun 1. Aust Prescr. 2018. PMID: 29922001 Free PMC article. Review. No abstract available.
-
Integrated disease management interventions for patients with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3. Cochrane Database Syst Rev. 2021. PMID: 34495549 Free PMC article.
-
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration.BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614. BMJ. 2018. PMID: 30413417 Free PMC article.
References
-
- Australian Council on Safety and Quality in Health Care. Second national report on improving patient safety: improving medication safety. Canberra: Australian Council on Safety and Quality in Health Care, 2002.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources